Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs REMEVi

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and REMEVi head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 9 · Grade B+

REMEVi

Visit REMEVi Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 87 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make REMEVi a bad call — it's best for people who value spanish-language support and want to compare a flexible four-week plan with a clearly priced longer commitment. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
78
Supply Reliability
95
88
Transparency
90
88
Access Breadth
93
96
Clinical Oversight
92
87
Track Record
88
87
CoreAge RxBrief Score 94 · 87REMEVi

Price, coverage & the tracker

CoreAge RxREMEVi
Brief Score94/100 (A)87/100 (B+)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

$199 / 4 weeks

24-week option: $954 upfront ($159 per four weeks).

Full price details

$199 every 4 weeks; $954 prepaid for 24 weeks ($159 per 4 weeks)

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

$269 / 4 weeks

24-week option: $1,350 upfront ($225 per four weeks).

Full price details

$269 every 4 weeks; $1,350 prepaid for 24 weeks ($225 per 4 weeks)

CoverageUS only; restrictions by state, confirmed at intake49 states and DC; excludes Louisiana
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

REMEVi: Four-week plans are $199 semaglutide / $269 tirzepatide. Lower per-cycle rates require 12 or 24 weeks prepaid; cancel at least 72 hours before renewal.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.